Skip to main content

Advertisement

SpringerLink
Log in

Late-Onset Schizophrenia

Epidemiology, Diagnosis, Management and Outcomes

  • Disease Management
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

The onset of schizophrenia for the first time in late life has been considered rare, and the nosology of the late-onset functional psychoses remains contentious. However, it is clear that a significant proportion of individuals with a diagnosis of schizophrenia do have the first onset of the illness in late and very late life. The clinical presentation of such patients shows some differences from patients with early-onset disease, particularly in having a lower prevalence of premorbid dysfunction, negative symptoms and formal thought disorder. The longitudinal course is variable, possibly a reflection of aetiological heterogeneity. Atypical antipsychotic agents would appear to have significant benefits in the treatment of this group of patients, given the particular vulnerability of the elderly to extrapyramidal adverse effects, notably tardive dyskinesia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Feighner JP, Robins E, Guze SB, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26: 57–63

    Article  PubMed  CAS  Google Scholar 

  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Press, 1987

    Google Scholar 

  3. Roth M. The natural history of mental disorder in old age. J Ment Sci 1955; 101: 281–301

    PubMed  CAS  Google Scholar 

  4. World Health Organization (WHO). International classification of diseases. 9th ed. Geneva: WHO, 1978

    Google Scholar 

  5. Keith SJ, Regier DA, Rae DS. Schizophrenic disorders. In: Robins LN, Regier DA, editors. Psychiatric disorders in America. New York: Free Press, 1991

    Google Scholar 

  6. Tien AY. Distributions of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol 1991; 26: 287–92

    Article  PubMed  CAS  Google Scholar 

  7. Christenson R, Blazer D. Epidemiology of persecutory ideation in an elderly population in the community. Am J Psychiatry 1984; 9(141): 1088–91

    Google Scholar 

  8. Henderson AS, Korten AE, Levings C, et al. Psychotic symptoms in the elderly: a prospective study in a population sample. Int J Geriatr Psychiatry 1998; 13(7): 484–92

    Article  PubMed  CAS  Google Scholar 

  9. Harris MJ, Jeste DV. Late-onset schizophrenia: an overview. Schizophr Bull 1988; 14(1): 39–55

    PubMed  CAS  Google Scholar 

  10. Castle DJ, Murray RM. The epidemiology of late-onset schizophrenia. Schizophr Bull 1993; 19(4): 691–9

    PubMed  CAS  Google Scholar 

  11. Parsons PL. Mental health of Swansea’s old folk. Br J Prev Soc Med 1964; 19: 43–7

    Google Scholar 

  12. Williamson J, Stokoe IH, Gray S, et al. Old people at home: their unreported needs. Lancet 1964; I: 1117–20

    Article  Google Scholar 

  13. Castle DJ. Gender and age at onset in schizophrenia. In: Howard R, Rabins P, editors. Late life schizophrenia: an international perspective. In press

  14. McLachlan G, Wekham J, McGrath J. Heterogeneity in schizophrenia: a mixture model based on age-of-onset, gender and diagnosis [abstract]. Schizophr Res 1998; 29: 21

    Article  Google Scholar 

  15. Castle DJ, Wessely S, Howard R, et al. Schizophrenia with onset at the extremes of adult life. Int J Geriatr Psychiatry 1997; 12: 712–7

    Article  PubMed  CAS  Google Scholar 

  16. Howard R, Castle DJ, O’Brien J, et al. Permeable walls, floors, ceilings and doors: partition delusions in late paraphrenia. Int J Geriatr Psychiatry 1992; 7: 719–24

    Article  Google Scholar 

  17. Pearlson GD, Kreger L, Rabins PV, et al. A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry 1989; 146(12): 1568–74

    PubMed  CAS  Google Scholar 

  18. Rabins P, Pauker S, Thomas J. Can schizophrenia begin after 44? Compr Psychiatry 1984; 25(3): 290–3

    Article  PubMed  CAS  Google Scholar 

  19. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer’s disease. Am J Psychiatry 1989; 146: 577–87

    PubMed  CAS  Google Scholar 

  20. Castle DJ, Howard R. What do we know about the aetiology of late-onset schizophrenia? Eur Psychiatry 1992; 7: 99–108

    Google Scholar 

  21. Howard R, Graham C, Sham P, et al. A controlled family study of late-onset non-affective psychosis (late paraphrenia). Br J Psychiatry 1997; 170: 511–4

    Article  PubMed  CAS  Google Scholar 

  22. Prager S, Jeste DV. Sensory impairment in late-life schizophrenia. Schizophr Bull 1993; 19(4): 755–71

    PubMed  CAS  Google Scholar 

  23. Fish F. Senile schizophrenia. J Ment Sci 1960; 106: 938–46

    PubMed  CAS  Google Scholar 

  24. Kay DWK, Roth M. Environmental and hereditary factors in the schizophrenias of old age (‘late paraphrenia’) and their bearing on the general problem of causation in schizophrenia. J Ment Sci 1961; 107: 649–86

    PubMed  CAS  Google Scholar 

  25. Kay DWK. Late paraphrenia and its bearing on the aetiology of schizophrenia. Acta Psychiatr Scand 1963; 39: 159–69

    Article  PubMed  CAS  Google Scholar 

  26. Almieda OP, Howard R, Forstl H, et al. Late paraphrenia: a review. Int J Geriatr Psychiatry 1992; 7: 543–8

    Article  Google Scholar 

  27. Holden NL. Late paraphrenia or the paraphrenias? A descriptive study with 10-year follow-up. Br J Psychiatry 1987; 150: 635–9

    Article  PubMed  CAS  Google Scholar 

  28. Häfner H, Hambrecht M, Löffler W, et al. Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle. Psychol Med 1998; 28: 351–65

    Article  PubMed  Google Scholar 

  29. Eaton WW, Mortensen PB, Herrman H, et al. Long-term course for hospitalisation in schizophrenia. Schizophr Bull 1992; 18: 217–28

    PubMed  CAS  Google Scholar 

  30. Sciolla A, Jeste DV. Use of antipsychotics in the elderly. Int J Psychiatry Clin Pract 1998; 2Suppl. 1: S27–34

    Google Scholar 

  31. Sweet RA, Pollock BG. New atypical antipsychotics: experience and utility in the elderly. Drugs Aging 1998; 12(2): 115–27

    Article  PubMed  CAS  Google Scholar 

  32. Jeste DV, Caligiuri MP, Paulsen AS, et al. Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch Gen Psychiatry 1995; 52: 756–65

    Article  PubMed  CAS  Google Scholar 

  33. Jeste DV, Eastham JH, Lacro JP, et al. Management of late-life psychosis. J Clin Psychiatry 1996; 57Suppl. 3: 39–45

    PubMed  Google Scholar 

  34. Herst L, Powell G. Is clozapine safe in the elderly? Aust N Z J Psychiatry 1997; 31: 411–17

    Article  PubMed  CAS  Google Scholar 

  35. Sajatovic M, Ramirez L, Garver D, et al. Clozapine therapy for older veterans. Psychiatr Serv 1998; 49(3): 340–4

    PubMed  CAS  Google Scholar 

  36. Salzman C, Vaccaro B, Lieff J, et al. Clozapine in older patients with psychosis and behavioural disruption. Am J Geriatr Psychiatry 1995; 3: 26–33

    Google Scholar 

  37. Wolters EC, Jansen ENH, Tuynman-Qua HG, et al. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson’s disease. Neurology 1996; 47: 1085–7

    Article  PubMed  CAS  Google Scholar 

  38. Daniel DG, Wozniak P, Mack RJ, the Sertindole Study Group, et al. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. Psychopharmacol Bull 1998; 34(1): 61–9

    PubMed  CAS  Google Scholar 

  39. Arvanitis LA, Miller BG, the Seroquel Trial 13 Study Group. Multiple fixed doses of ‘seroquel’(quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997; 42(4): 233–46

    Article  PubMed  CAS  Google Scholar 

  40. Wong SL, Cao G, Mack RJ, et al. Pharmacokinetics of sertindole in healthy young and elderly male and female subjects. Clin Pharmacol Ther 1997; 62(2): 157–64

    Article  PubMed  CAS  Google Scholar 

  41. Leucht S, Pitshel-Walz G, Abraham D, et al. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomised controlled trials. Schizophr Res 1999; 4; 35: 51–68

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Directorate of Mental Health Services, Fremantle Hospital and Health Service, Alma Street Centre, Alma Street, Fremantle, Western Australia, 6160, Australia

    Peter A. Wynn Owen &  David J. Castle (Clinical Director)

Authors
  1. Peter A. Wynn Owen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Castle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Castle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wynn Owen, P.A., Castle, D.J. Late-Onset Schizophrenia. Drugs Aging 15, 81–89 (1999). https://doi.org/10.2165/00002512-199915020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199915020-00002

Keywords

Search

Navigation